Nuveen, LLC Savara Inc Transaction History
Nuveen, LLC
- $363 Billion
- Q3 2025
A detailed history of Nuveen, LLC transactions in Savara Inc stock. As of the latest transaction made, Nuveen, LLC holds 236,835 shares of SVRA stock, worth $1.03 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
236,835
Previous 320,273
26.05%
Holding current value
$1.03 Million
Previous $730,000
14.11%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding SVRA
# of Institutions
132Shares Held
160MCall Options Held
14.3KPut Options Held
24.9K-
Nea Management Company, LLC Timonium, MD24.5MShares$106 Million5.38% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA17.6MShares$76.4 Million19.88% of portfolio
-
Vr Adviser, LLC New York, NY12.7MShares$55 Million6.78% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA12.4MShares$53.7 Million4.88% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA11.5MShares$49.7 Million1.71% of portfolio
About Savara Inc
- Ticker SVRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 114,043,000
- Market Cap $495M
- Description
- Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.